Genome sequence and analysis of methylotrophic yeast Hansenula polymorpha DL1 NV Ravin, MA Eldarov, VV Kadnikov, AV Beletsky, J Schneider, ... BMC genomics 14, 1-20, 2013 | 107 | 2013 |
Computationally guided high-throughput design of self-assembling drug nanoparticles D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ... Nature nanotechnology 16 (6), 725-733, 2021 | 70 | 2021 |
Telomerase RNA biosynthesis and processing EM Smekalova, OS Shubernetskaya, MI Zvereva, EV Gromenko, ... Biochemistry (Moscow) 77, 1120-1128, 2012 | 51 | 2012 |
lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference EM Smekalova, YV Kotelevtsev, D Leboeuf, EY Shcherbinina, AS Fefilova, ... Biochimie 131, 159-172, 2016 | 35 | 2016 |
Structural features of the telomerase RNA gene in the naked mole rat Heterocephalus glaber SA Evfratov, EM Smekalova, AV Golovin, NA Logvina, MI Zvereva, ... Acta Naturae (англоязычная версия) 6 (2 (21)), 41-47, 2014 | 21 | 2014 |
On multilabel classification methods of incompletely labeled biomedical text data A Kolesov, D Kamyshenkov, M Litovchenko, E Smekalova, A Golovizin, ... Computational and mathematical methods in medicine 2014, 2014 | 20 | 2014 |
Specific features of telomerase RNA from Hansenula polymorpha EM Smekalova, AN Malyavko, MI Zvereva, AV Mardanov, NV Ravin, ... RNA 19 (11), 1563-1574, 2013 | 19 | 2013 |
TERRA–a calling card for telomerase E Smekalova, P Baumann Molecular cell 51 (6), 703-704, 2013 | 18 | 2013 |
In vivo RNAi-mediated eIF3m knockdown affects ribosome biogenesis and transcription but has limited impact on mRNA-specific translation EM Smekalova, MV Gerashchenko, PBF O’Connor, CA Whittaker, ... Molecular Therapy-Nucleic Acids 19, 252-266, 2020 | 14 | 2020 |
Gene editing technologies to target HBV cccDNA MG Martinez, E Smekalova, E Combe, F Gregoire, F Zoulim, B Testoni Viruses 14 (12), 2654, 2022 | 12 | 2022 |
Hansenula Polymorpha TERT: a telomerase catalytic subunit isolated in recombinant form with limited reverse transcriptase activity EM Smekalova, OA Petrova, MI Zvereva, OA Dontsova Acta Naturae (англоязычная версия) 4 (1 (12)), 70-73, 2012 | 11 | 2012 |
Translation elongation factor 2 depletion by siRNA in mouse liver leads to mTOR-independent translational upregulation of ribosomal protein genes MV Gerashchenko, MV Nesterchuk, EM Smekalova, JA Paulo, ... Scientific reports 10 (1), 15473, 2020 | 10 | 2020 |
Identification of additional telomerase component of the yeast H. polymorpha is a step towards understanding the complex at the atomic level. O Petrova, E Smekalova, M Zvereva, V Lamzin, O Dontsova Doklady Biochemistry & Biophysics 455 (1), 2014 | 5 | 2014 |
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo EM Smekalova, MG Martinez, E Combe, A Kumar, S Dejene, D Leboeuf, ... Molecular Therapy-Nucleic Acids 35 (1), 2024 | 4 | 2024 |
Isolation of active yeast telomerase protein Est3p and investigation of its dimerization in vitro YS Sharanov, EM Smekalova, MI Zvereva, OA Dontsova Biochemistry (Moscow) 72, 702-706, 2007 | 2 | 2007 |
CCCDNA inactivation using cytosine base editors MG Martinez, E Smekalova, E Combe, MS Packer, LA Barrera, S Dejene, ... Hepatology 74, 504A-504A, 2021 | 1 | 2021 |
Detection of the telomerase activity and identification of the telomerase components in thermotolerant yeast Hansenula polymorpha EM Smekalova, MI Zvereva, OA Dontsova FEBS JOURNAL 278, 90-90, 2011 | 1 | 2011 |
ADENINE BASE EDITING SILENCES HBsAg EXPRESSION AND INHIBITS HEPATITIS B VIRAL REPLICATION IN HBV MOUSE MODELS EM Smekalova, A Kumar, E Combe, S Dejene, CY Chen, D Leboeuf, ... HEPATOLOGY 78, S553-S554, 2023 | | 2023 |
Compositions and methods for treating hepatitis b E Smekalova, M Packer, F Gregoire, L Barrera, G Ciaramella US Patent App. 17/610,119, 2023 | | 2023 |
Compositions and methods for treating hepatitis b E Smekalova, M Packer, F Gregoire, L Barrera, G Ciaramella | | 2020 |